Compare PRPO & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | LFVN |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.4M | 51.5M |
| IPO Year | 2000 | 1996 |
| Metric | PRPO | LFVN |
|---|---|---|
| Price | $30.50 | $5.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 14.9K | ★ 170.8K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.56% |
| EPS Growth | 92.15 | ★ 226.09 |
| EPS | N/A | ★ 0.19 |
| Revenue | $24,049,000.00 | ★ $203,204,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $28.53 |
| Revenue Growth | ★ 29.77 | 1.86 |
| 52 Week Low | $5.94 | $3.90 |
| 52 Week High | $32.40 | $15.00 |
| Indicator | PRPO | LFVN |
|---|---|---|
| Relative Strength Index (RSI) | 55.33 | 55.96 |
| Support Level | $22.96 | $4.10 |
| Resistance Level | N/A | $5.37 |
| Average True Range (ATR) | 1.71 | 0.46 |
| MACD | 0.15 | 0.06 |
| Stochastic Oscillator | 61.12 | 54.79 |
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.